GSK Competitors & Alternatives
Compare GSK plc with similar stocks in the same industry
Drug Manufacturers - General
GSK
Main Stock$50.60
Tradestie Score
41
Market Cap
$91.59B
P/E Ratio
17.9
Revenue Growth
0.0%
Analyst Upside
+16.8%
Top Competitors
16 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVS
Novartis AG
|
$160.32
|
$254.99B | 31.2 | 41 | Compare |
|
MRK
Merck & Co., Inc.
|
$147.18
|
$225.13B | 149.5 | 50 | Compare |
|
AMGN
Amgen Inc
|
$468.11
|
$160.70B | 27.0 | 41 | Compare |
|
PFE
Pfizer Inc.
|
$29.45
|
$154.70B | 41.9 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$169.73
|
$137.92B | - | 37 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$48.43
|
$121.27B | 24.0 | 31 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$62.91
|
$96.54B | 13.9 | 48 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$253.40
|
$22.61B | 109.6 | 43 | Compare |
|
GRFS
Grifois, S.A.
|
$8.84
|
$6.78B | 10.6 | 31 | Compare |
|
OGN
Organon & Co.
|
$13.89
|
$2.86B | 17.8 | 46 | Compare |
More GSK Analysis
Data updated: Nov 12, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
16 stocks in this industry